📊 Score Breakdown
Offering Ability
20
Cash Runway
0
Float Risk
25
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for BCAL.
💹 Market Data
Market Cap$609.20M
Shares Outstanding32.16M
Float22.71M
Cash$411.14M
Debt$53.41M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 5.1% shares (2025Q4 vs prior)
144 institutional holders · 20.37M shares
#1
WELLINGTON MANAGEMENT GROUP LLP
2.88M shares
#2
ALLIANCEBERNSTEIN L.P.
2.35M shares
#3
ENDEAVOUR CAPITAL ADVISORS INC
1.77M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest679.8K
Days to Cover4.0
% of Float3.0%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
4
INSIDER TRANSACTION
Apr 22, 2026
4
INSIDER TRANSACTION
Apr 16, 2026
4
INSIDER TRANSACTION
Apr 13, 2026
4
INSIDER TRANSACTION
Apr 13, 2026
4
INSIDER TRANSACTION
Mar 26, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for BCAL
📊 BCAL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 BCAL Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.